Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3614
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00620503 | Proellex® Pharmacokinetic Bridging Study II | ||
| NCT00387283 | Pharmacokinetic Study in Cerebral Spinal Fluid After a Single Dose of AVI-4020 | ||
| NCT06137573 | Human Mass Balance and Biotransformation Study of [14C]TNP-2198 | ||
| NCT04848714 | Pharmacokinetic Study Protocol of ANAWIDOW Lyophilized Powder for Solution for Intravenous Use in Fasting Conditions | ||
| NCT03041116 | Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Participants | ||
| NCT02471716 | Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor | ||
| NCT03029234 | Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple Myeloma | ||
| NCT01674634 | Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures | ||
| NCT06598371 | A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors | ||
| NCT06713434 | Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa | ||
| NCT03536728 | Oral AMXT 1501 Dicaprate in Combination With DFMO | ||
| NCT01299298 | A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Doses of Mipomersen in Japanese Healthy Volunteers | ||
| NCT01067365 | Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism | ||
| NCT05820100 | Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDT | ||
| NCT01784536 | Open Label Study Evaluating the Effects of a Single Oritavancin Infusion on Cytochrome P450 in Healthy Volunteers | ||
| NCT03502434 | A Repeat Insult Patch Test (RIPT) Study Evaluating the Sensitization Potential of Topical SM04755 Solution in Healthy Volunteers | ||
| NCT04804566 | Understanding Fabry Disease Therapy Choices Through the Eyes of the Patients | ||
| NCT06345794 | A Study to Assess LY4100511 (DC-853) in Healthy Adult Participants | ||
| NCT05375994 | Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients | ||
| NCT06788639 | A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting | ||
| NCT02449616 | Evaluation of Repeat Administration of Purified Poloxamer 188 | ||
| NCT04676711 | A Study of GFH312 in Healthy Subjects | ||
| NCT03375164 | A Gene Transfer Therapy Study to Evaluate the Safety of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) | ||
| NCT06983028 | Atacicept in Multiple Glomerular Diseases | ||
| NCT04052204 | Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors | ||
| NCT05511844 | Study of ORM-5029 in Subjects With HER2-Expressing Advanced Solid Tumors | ||
| NCT02780609 | Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma | ||
| NCT02498912 | Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors | ||
| NCT05511519 | Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis | ||
| NCT05619536 | Study of CD388 Subcutaneous Administration in Healthy Japanese Subjects | ||
| NCT02189304 | Pharmacokinetics and Safety Study of PT010 in Healthy Subjects | ||
| NCT07673744 | A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG) | ||
| NCT02310906 | Phase I/II Study of SRP-4053 in DMD Patients | ||
| NCT02083965 | Pharmacokinetics of rFVIIIFc at Two Vial Strengths | ||
| NCT00813293 | Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer | ||
| NCT05081193 | Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer | ||
| NCT07204938 | A Long-Term Study of Navenibart in Participants With Hereditary Angioedema | ||
| NCT00876655 | Exploratory Pharmacokinetic and Bioavailability Study of 2 Capsule Formulations of Torezolid Phosphate | ||
| NCT04247815 | Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RA | ||
| NCT05223699 | Study of MGTA-117 in Patients With Adult Acute Myeloid Leukemia (AML) and Myelodysplasia-Excess Blasts (MDS-EB) | ||
| NCT07542314 | Study to Evaluate the Safety and Effectiveness of ELEVIDYS in Participants With Duchenne Muscular Dystrophy Treated in a Post-Marketing Setting | ||
| NCT01495338 | A Comparison of the Safety and Comfort of AC-170 | ||
| NCT04572776 | Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain | ||
| NCT04227106 | Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) | ||
| NCT05881408 | A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) | ||
| NCT02381652 | Repeat Injection of Cingal® for Osteoarthritis of the Knee | ||
| NCT03846843 | OCR002-SP103 - Oral Immediate Release Study | ||
| NCT03818815 | A Study to Assess the Safety, Tolerability and Efficacy of OP0201 as an Adjunct Treatment for Acute Otitis Media in Infants and Children Aged 6 to 24 Months | ||
| NCT07623525 | DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia | ||
| NCT03272568 | Extended Half Life Factor (EHF) Products For Heavy Menstrual Bleeding in Hemophilia Carriers |
